Zogenix Inc. has acquired Brabant Pharma
Target Company Name:
Country:
Advisory:
Sector:
Partner:
Country:
Advisory:
Sector:
Partner:
Brabant's assets include worldwide development and commercialisation rights to Brabafen, low-dose fenfluramine, for the treatment of Dravet Syndrome.
USA Based - Pharmaceutical Company
Zogenix Acquires UK Bases Brabant Pharma for up to $130m
Advisor :
Zeus
Zeus